Healthcare Global Enterprises Ltd

NSE: HCG · BSE: 539787 · Healthcare · 32 announcements

Share price: ₹657.60
Market cap: ₹9,818 Cr
Revenue (annual): ₹2,545 Cr
Net profit (annual): ₹13.76 Cr
P/E (TTM): 430.6×Sector 53.1×
Promoter holding: 64.21%+0.00% QoQ
FII holding: 2.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Annual General Meeting 5 Other Announcement 4 Merger & Restructuring 4 Financial Results 3 Results Update 2 Fund Raise 2 Board Meeting Date 2 Management Change 1 Employee Stock Options 1 Capacity Expansion 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

6 Aug 2026 19:43 IST BSE

Merger & Restructuring

Healthcare Global Enterprises Merger & Restructuring Worth ₹16 Cr

HealthCare Global Enterprises approved a further investment of up to INR 16 Crore in its wholly-owned subsidiary, HCG Rajkot Hospitals LLP.

Value: ₹16.00 Cr
Execution: on or before 30 September 2026

Read the filing ↗

4 Aug 2026 19:25 IST BSE

Merger & Restructuring

Healthcare Global Enterprises Merger & Restructuring Worth ₹0.38 Cr

HCG's subsidiary will acquire a 26% stake in Epic Vighnaharta Renewable Energy for ₹0.38 Crore. This investment enables captive solar power consumption.

Value: ₹0.38 Cr

Read the filing ↗

29 Jun 2026 19:47 IST BSE

Merger & Restructuring

Healthcare Global Enterprises Merger & Restructuring Worth ₹37.64 Cr

HealthCare Global Enterprises completed the divestment of its subsidiary BACC Health Care. The total consideration for the transaction is ₹37.64 Crore.

Value: ₹37.64 Cr

Read the filing ↗

19 May 2026 23:05 IST BSE

Merger & Restructuring

Healthcare Global Enterprises Merger & Restructuring Worth ₹37.64 Cr

HealthCare Global Enterprises is divesting its entire stake in BACC Health Care for ₹37.64 Crore. The sale to Inviga Healthcare Fund I enables strategic cancer-care focus.

Value: ₹37.64 Cr
Execution: 4-5 weeks

Read the filing ↗